New Haven, Conn. -- The
National Cancer Institute recently awarded a five-year, $7.5 million program project grant to investigators at the
Yale School of Medicine to continue studies on the role of viruses and mutant cellular proteins in tumorigenic transformation of cells.
This grant, "Program on the Molecular Basis of Viral and Cellular Transformation," is currently in its 31st year and is one of the largest and longest-running basic science grants at Yale. It coordinates studies to understand how viral genes and related cellular genes cause cells to escape normal growth controls and induce cancer.
"Because viruses are so well-defined and relatively simple compared to their host cells, we are optimistic that studies supported by this grant will continue to identify new targets for therapy and suggest new approaches to prevent and treat cancers," said principal investigator Daniel DiMaio, M.D., Waldemar Von Zedtwitz Professor of Genetics and vice chair of the Department of Genetics.
DiMaio studies human papillomaviruses (HPV), the causative agents of cervical cancer. His laboratory has shown that HPV oncogenes must be expressed continuously in cervical cancer cells for the cells to maintain their malignant characteristics, validating the viral genes as new therapeutic targets. In the current granting period, the DiMaio laboratory will continue to dissect the pathways activated when HPV oncogenes are repressed in cervical cancer cells.
Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus, two herpesviruses that are unusual in their ability
'"/>
Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
22-Sep-2004
Page: 1 2 Related biology news :1.
K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense2.
5 Million award for pioneering project to train new breed of scientists3.
2 Million of yeast to triple available drug treatments4.
$10 Million center for theoretical biological physics created at UCSD by NSF5.
Million dollar grant by the Paul G. Allen Foundation for Medical Research to University of Washington medical scientist program6.
$14 Million NIH grant launches heart, lung, blood and sleep disorders center at the Jackson Laboratory7.
NSF awards $4.2 Million grants to three coastal sites for long-term ecological research8.
JDF awards $10 Million to Childrens Hospital of Pittsburgh and University of Pittsburgh for new research center to help speed diabetes cure9.
AVAX Technologies receives an additional $3.0 Million (AUD) investment in Australian joint venture from Australian Vaccine Technologies Ltd.10.
Columbia University College of Physicians and Surgeons receives $2.4 Million grant from Howard Hughes Medical Institute11.
UCSF School of Medicine receives $3.8 Million grant for biomedical research